ArticleCancer immunology, immunotherapy : CII2022

SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.

Lu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.